Synutra International Retains Investor Relations International to Lead Shareholder Communications Program

QINGDAO, China & ROCKVILLE, Md.--(BUSINESS WIRE)--Synutra International (Nasdaq: SYUT), a leading infant formula company in China, and a producer, marketer and seller of nutritional products for infants, children and adults, today announced that it has retained Investor Relations International (IRI) to develop and lead its shareholder communications program.

“We are pleased to have Investor Relations International working with us to raise our profile and ensure the broad investment community fully understands the growth potential that lies ahead for Synutra in China’s market for infant formulas and nutritional products”

As investor relations advisors for Synutra, Los Angeles-based IRI will raise investor awareness of the Company’s growing position as one of China’s leading providers of formulas and nutritional products through its proprietary investor relations model that leverages the distribution of new media technologies with traditional direct communications. The IRI program is designed to expand the Company’s capital resources by broadening the Company’s shareholder base and development of analyst coverage.

“We are pleased to have Investor Relations International working with us to raise our profile and ensure the broad investment community fully understands the growth potential that lies ahead for Synutra in China’s market for infant formulas and nutritional products,” said Liang Zhang, Chairman and CEO of Synutra. “Our company is at a pivotal point in its history as we rebound from last year’s recall and look forward to returning to our history of continued revenue and earnings growth. IRI is well-known for its expertise in generating institutional and retail investor interest, liquidity and shareholder value – all of which will prove to be crucial to the success of our next growth phase,” concluded Zhang.

If you would like to be added to Synutra’s investor email lists or have additional questions, please contact Haris Tajyar with Investor Relations International at [e-mail] or at 818-382-9702.

About Synutra

Synutra operates nine subsidiaries developing, producing, distributing and selling dairy-based nutritional products across the People’s Republic of China. It offers its products for infants, children, adults, pregnant women and nursing mothers under the “Sheng Yuan” or “Synutra” master brand and several sub-brands, including “Super,” “U-Smart” and “Minshan.” The Group’s extensive sales network covers 29 provinces and provincial-level municipalities in China, and comprises over 420 distributors and over 1,000 sub-distributors who sell Synutra’s products in nearly 63,400 retail outlets.

For further information on Synutra, please visit www.synutra.com.

The information contained herein includes statements, estimates, projections, guidance or outlook that constitute “forward-looking” statements as defined under U.S. federal securities laws. Generally the words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “plan,” “project,” “will” and similar expressions, identify forward-looking statements, which generally are not historical in nature. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.